Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties

Details for Australian Patent Application No. 2006315684 (hide)

Owner Auspex Pharmaceuticals, Inc.

Inventors Gant, Thomas G.; Sarshar, Sepehr

Agent EF WELLINGTON & CO

Pub. Number AU-A-2006315684

PCT Pub. Number WO2007/058998

Priority 60/741,530 01.12.05 US; 60/736,581 14.11.05 US

Filing date 13 November 2006

Wipo publication date 24 May 2007

International Classifications

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

A61K 31/443 (2006.01)

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

Event Publications

29 May 2008 PCT application entered the National Phase

  PCT publication WO2007/058998 Priority application(s): WO2007/058998

7 June 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006315686-Modulation of angiogenesis by A-beta peptide fragments

2006315675-Quinazolines useful as modulators of voltage gated ion channels